Experimental Biomedical Research
Concurrent thiol-disulfide and glutathione redox imbalance in acute ischemic stroke and its relationship to functional outcome: A prospective case-control study
By Faruk Danış, Murat Alışık, Kaan Çelik and 1 others.
Loading your page…
Experimental Biomedical Research
By Faruk Danış, Murat Alışık, Kaan Çelik and 1 others.
Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.
To concurrently assess serum thiol-disulfide and erythrocyte glutathione redox status in patients with acute ischemic stroke and determine their associations with stroke severity, infarct volume, and 90-day functional outcome.
In this prospective case-control study, 85 stroke patients sampled within 24 hours of onset and 79 healthy controls were studied. Native and total thiol were measured by an automated assay and reduced (GSH) and total glutathione by a validated colorimetric method, with disulfide and oxidized glutathione (GSSG) derived by calculation. Markers were compared between groups with effect sizes and age- and sex-adjustment, correlated with NIHSS and infarct volume, and tested against poor 90-day outcome (modified Rankin Scale 3-6) in exploratory analyses.
Both systems shifted toward oxidation. Native and total thiol were lower and the disulfide fraction higher; the glutathione system shifted most, with lower GSH, higher GSSG, and a markedly higher GSSG/GSH ratio (0.119 vs 0.046; rank-biserial r= 0.88; adjusted p<0.001). No marker correlated with NIHSS or infarct volume. A poor outcome occurred in 32 of 85 patients (37.6%). Among the 50 patients with glutathione measured, 16 had a poor outcome; the ratio was associated with it univariably (odds ratio 2.27 per SD, 95% CI 1.08-4.76) and after age adjustment, but not after adjustment for admission NIHSS (area under the curve 0.72).
Acute ischemic stroke was characterized by a coordinated redox imbalance, most pronounced in erythrocyte glutathione homeostasis. The GSSG/GSH ratio was associated with poor 90-day outcome and merits further validation as a prognostic marker.
Published in Experimental Biomedical Research. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.